Status
Conditions
Treatments
About
The HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in patients with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant. Participants will be followed for recurrent clinical events, every 6 months, for a maximum of 10 years.
Full description
HARP is a multi-center, observational study which enrolls men and women with MI who are referred for cardiac catheterization. Eligible participants with MINOCA (defined as no stenosis of >50% in any major epicardial vessel) will undergo optical coherence tomography (OCT) at the time of diagnostic angiography and cardiac magnetic resonance imaging (CMR).
Participants will also have the option to enroll in the HARP-Platelet Sub-Study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Acute ischemic symptoms compatible with diagnosis of MI, such as chest pain or anginal equivalent symptoms at rest or new onset exertional anginal equivalent symptoms
Objective evidence of MI (either or both of the following):
Willing to provide informed consent and comply with all aspects of the protocol
Age ≥ 21 years
Exclusion criteria
450 participants in 2 patient groups
Loading...
Central trial contact
Harmony R Reynolds, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal